The Cell & Gene Therapy Manufacturing Services Market Size was valued at USD 16.92 billion in 2022 and is expected to reach USD 30.86 billion by 2030, and grow at a CAGR of 7.8% over the forecast period 2023-2030.

The Cell & Gene Therapy Manufacturing Services Market is experiencing significant growth and is poised to revolutionize the healthcare industry. This market encompasses a wide range of services that support the manufacturing and development of cell and gene therapies, which hold immense potential for treating various diseases and conditions.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/1187

Cell therapy involves the transplantation or infusion of living cells into a patient's body to restore or improve their function. On the other hand, gene therapy aims to introduce genetic material into a patient's cells to correct or modify genetic disorders. Both these therapies have shown promising results in clinical trials, offering hope for patients with previously untreatable conditions.

However, the manufacturing process for cell and gene therapies is complex and requires specialized expertise, infrastructure, and equipment. This has led to the emergence of companies providing manufacturing services tailored specifically for these therapies. These service providers offer end-to-end solutions, including process development, scale-up, manufacturing, quality control testing, storage, and distribution.

KEY MARKET SEGMENTS

By Therapy Type

  • Gene Therapy Manufacturing
  • Cell Therapy Manufacturing
    • Non-Stem Cell Therapy
    • Stem Cell Therapy

By Scale Type

  • Commercial Scale Manufacturing
  • Pre-commercial/ R&D Scale Manufacturing

By Mode type

  • In-house Manufacturing
  • Contract Manufacturing

By Workflow type

  • Cell Processing
  • Fill & Finish Operations
  • Vector Production
  • Analytical And Quality Testing
  • Cell Banking
  • Process Development
  • Raw Material Testing
  • Others

Major Players Listed in the Report are as Follows:

Merck KGaA, Thermo Fisher Scientific, Catalent Inc., Lonza, Takara Bio Inc., Wuxi Advanced Therapies, F. Hoffmann-La Roche Ltd, Samsung Biologics, Bluebird Bio Inc., Novartis AG, Boehringer Ingelheim, Hitachi Chemical Co., Ltd., Miltenyi Biotec, Cellular Therapeutics.

Other Report

Artificial Hip Joint Market Analysis

Antiperspirants and Deodorants Market Analysis

Advanced Wound Care Market Analysis

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)